Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

Since commercial SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen rapid detection tests (Ag-RDTs) display broad diagnostic efficiency, this study aimed to evaluate the clinical performance of Fluorecare SARS-CoV-2 Spike Protein Test Kit in a real-life scenario.

Guardado en:

Detalles Bibliográficos
Autores principales:	Salvagno Gian Luca, Gianfilippi Gianluca, Pighi Laura, De Nitto Simone, Henry Brandon M., Lippi Giuseppe
Formato:	article
Lenguaje:	EN ES
Publicado:	De Gruyter 2021
Materias:	covid-19 diagnosis immunoassay laboratory medicine sars-cov-2 Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/14ecfcde489d42ceb1e699de7d1452a4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:14ecfcde489d42ceb1e699de7d1452a4
record_format	dspace
spelling	oai:doaj.org-article:14ecfcde489d42ceb1e699de7d1452a42021-12-05T14:10:39ZReal-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit2628-491X10.1515/almed-2021-0041https://doaj.org/article/14ecfcde489d42ceb1e699de7d1452a42021-05-01T00:00:00Zhttps://doi.org/10.1515/almed-2021-0041https://doaj.org/toc/2628-491XSince commercial SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen rapid detection tests (Ag-RDTs) display broad diagnostic efficiency, this study aimed to evaluate the clinical performance of Fluorecare SARS-CoV-2 Spike Protein Test Kit in a real-life scenario.Salvagno Gian LucaGianfilippi GianlucaPighi LauraDe Nitto SimoneHenry Brandon M.Lippi GiuseppeDe Gruyterarticlecovid-19diagnosisimmunoassaylaboratory medicinesars-cov-2Medical technologyR855-855.5ENESAdvances in Laboratory Medicine, Vol 2, Iss 3, Pp 409-412 (2021)
institution	DOAJ
collection	DOAJ
language	EN ES
topic	covid-19 diagnosis immunoassay laboratory medicine sars-cov-2 Medical technology R855-855.5
spellingShingle	covid-19 diagnosis immunoassay laboratory medicine sars-cov-2 Medical technology R855-855.5 Salvagno Gian Luca Gianfilippi Gianluca Pighi Laura De Nitto Simone Henry Brandon M. Lippi Giuseppe Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
description	Since commercial SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen rapid detection tests (Ag-RDTs) display broad diagnostic efficiency, this study aimed to evaluate the clinical performance of Fluorecare SARS-CoV-2 Spike Protein Test Kit in a real-life scenario.
format	article
author	Salvagno Gian Luca Gianfilippi Gianluca Pighi Laura De Nitto Simone Henry Brandon M. Lippi Giuseppe
author_facet	Salvagno Gian Luca Gianfilippi Gianluca Pighi Laura De Nitto Simone Henry Brandon M. Lippi Giuseppe
author_sort	Salvagno Gian Luca
title	Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
title_short	Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
title_full	Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
title_fullStr	Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
title_full_unstemmed	Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
title_sort	real-world assessment of fluorecare sars-cov-2 spike protein test kit
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/14ecfcde489d42ceb1e699de7d1452a4
work_keys_str_mv	AT salvagnogianluca realworldassessmentoffluorecaresarscov2spikeproteintestkit AT gianfilippigianluca realworldassessmentoffluorecaresarscov2spikeproteintestkit AT pighilaura realworldassessmentoffluorecaresarscov2spikeproteintestkit AT denittosimone realworldassessmentoffluorecaresarscov2spikeproteintestkit AT henrybrandonm realworldassessmentoffluorecaresarscov2spikeproteintestkit AT lippigiuseppe realworldassessmentoffluorecaresarscov2spikeproteintestkit
_version_	1718371824759209984

Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

Ejemplares similares